Leyton is pleased to announce its strategic partnership with MEDTEQ+.
This partnership marks a turning point in the support of Canadian companies in the healthcare and medical technology sector, as it will enable them to support innovation and foster growth.
Together, Leyton and MEDTEQ+ will implement concrete solutions to help companies leverage their innovation potential while optimizing their resources. Leyton will provide its in-depth knowledge of research and development, subsidies and tax credits, while MEDTEQ+ will contribute its specific expertise in supporting the healthcare technology, biotechnology and medical devices sectors.
Thanks to this collaboration, companies in the sector will be able to benefit from comprehensive support, covering the search for funding, the management of innovation projects and support for commercialization. They will thus benefit from enhanced support in dealing with the financial and technical challenges that arise when implementing innovation projects.
The partnership between MEDTEQ+ and Leyton represents a decisive step towards transforming the healthcare industry and is part of a long-term vision to strengthen Canada’s position as a world leader in medical technologies. The two companies will help to create sustainable growth opportunities for players in the sector, while enhancing the quality of care and continuous innovation.